MedPath

Emodan

Brand Name: Emodan

Generic Name: Ondansetron (as Hydrochloride)

Active
Registration Number

DR-XY29866

Dosage Form

Solution For Injection (I.M./I.V.)

Issuance Date

February 22, 2024

Expiry Date

August 9, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength2 mg/mL (8 mg/4 mL)
Packaging4mL USP Type I Colorless Glass Ampoule (Box of 5's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antiemetic
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Ondansetron (as Hydrochloride)Active
Monograph: Ondansetron

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.